1,814 product recalls found in this category. Browse through all safety alerts and stay informed.
High Activity Category
This category has a significant number of recalls. Please check regularly for updates.
Mylan Institutional LLC recalled 800 vials of Haloperidol Lactate Injection on October 10, 2025, due to incorrect RFID tag labels. The product may pose a risk due to potential mislabeling affecting tracking and administration. Healthcare providers should stop using the product immediately and follow up with Safecor Health for guidance.
Gabriel Mineral Sunscreen SPF 50 is recalled. The FDA-listed recall number D-0190-2026 covers 1617 tubes distributed to California, Colorado, Florida, Puerto Rico and Washington. The recall cites CGMP deviations as the hazard. Consumers should stop using the product immediately and contact CA Botana International or a healthcare provider for guidance.
Beauty4Pros LLC recalls Karina Daily Moisturizer SPF 25 distributed to CA, CO, FL, PR, WA after CGMP deviations. 1,492 tubes affected. Stop use immediately and contact CA Botana International for guidance.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, 10 capsules per blister pack, distributed nationwide in the United States. The recall cites failed impurities and degradation specifications from routine stability testing, specifically an out-of-spec Highest Unknown Impurity. Consumers and healthcare providers should stop using this product immediately and contact The Harvard Drug集团
Thoratec recalled 8,399 CentriMag Blood Pumps on October 10, 2025, due to a significant malfunction risk. The blood pump may not securely lock into the motor, potentially leading to serious health complications. The recall affects models distributed worldwide, including across the United States and several countries.
CLEARSTEM You Are Sunshine SPF 50 sunscreen from VISAGE is recalled for CGMP deviations. 4,890 bottles distributed to CA, CO, FL, PR, and WA are affected. Consumers should stop using the product immediately and contact CA Botana International or a healthcare provider for guidance.
CA BOTANA International recalled 810 tubes of Doctor D. Schwab Weh-Weh Natural Pain Relief Gel due to CGMP deviations. The recall covers tubes distributed to California, Colorado, Florida, Puerto Rico and Washington. Consumers should stop using the product immediately and contact CA BOTANA for guidance.
Elixir by Coco March Mineral Sunscreen SPF 50 was recalled on 2025-10-10 and remains active. Manufactured or distributed by CA Botana International and distributed in several states. The FDA recall cites CGMP deviations as the hazard. Consumers and healthcare providers should stop using the product immediately and consult a healthcare provider for guidance.
Lannett Company, Inc. recalled 46,848 bottles of NIACIN Extended-release Tablets, 1,000 mg, Rx Only, distributed nationwide. The product failed dissolution specifications. Patients and healthcare providers should stop using it immediately and await recall instructions.
Doctor D. Schwab recalled 555 tubes of Controlling Balm with Tea Tree Oil after identifying CGMP deviations. The product may not meet quality standards, posing a safety risk. Consumers should stop using the balm immediately and contact CA BOTANA for guidance.
CA BOTANA International recalled 874 tubes of Sea Enzyme Ultra Umbrella Sunscreen SPF 30. The recall, active as of Dec 3, 2025, covers tubes with lot D53950 and expiration 05/31/2027 distributed in CA, CO, FL, PR, and WA. The agency cites CGMP deviations as the hazard. Consumers should stop using this product immediately and contact CA BOTANA for guidance or consult a healthcare provider.
STAQ Pharma recalled Ketamine Hydrochloride injections distributed nationwide in the United States. The labeling has incorrect or missing lot and expiration date information. Stop using the product and contact STAQ Pharma or your healthcare provider for guidance.
USV Private recalled 8,952 bottles of Olopatadine Hydrochloride Ophthalmic Solution USP 0.1%. The product was distributed nationwide in the United States. The defect is failure of impurities/degradation specifications due to an unspecified impurity exceeding the limit. Stop using immediately and contact USV Private Limited or a healthcare provider for guidance.
Glycar SA recalls 18 SJM Pericardial Patch with EnCap Technology 5x10 cm distributed in the US to healthcare facilities. The lot may not meet the required tensile strength specification. Stop use and follow manufacturer instructions provided by Glycar and your healthcare provider. Notification was issued by email.
C-RAD POSITIONING AB recalled 189 Catalyst and Catalyst+ devices on October 9, 2025, due to issues with stereotactic radiosurgery (SRS) treatment. The defect may lead to incorrect patient positioning, potentially compromising treatment effectiveness. The recall affects devices distributed across 37 countries, including the United States.
Pivotal Health Solutions is recalling 34 Quantum Q400 intersegmental heated massage tables sold nationwide in the United States, Canada and Japan. The recall cites heat-function components that can be damaged over time when pressed, risking overheating, smoldering and melting of the vinyl cushion. Clinicians and patients should stop using the device immediately and await manufacturer instructions.
STAQ Pharma recalled FentaNYL Citrate PF IV injection nationwide after labeling left incorrect or missing lot and expiration dates. Healthcare providers must stop using the product immediately. STAQ Pharma will provide recall instructions by letter.
27,868 blister packs of Sucralfate Tablets, 1 g, distributed nationwide by American Health Packaging are recalled. The recall stems from CGMP deviations that prevent the firm from assuring product identity, strength, quality and purity. Health providers and consumers should stop using the product immediately and await guidance.
ibspot recalled Taoscare Motion Sickness Patches, 36-count boxes, sold in Wyoming and Virginia. The recall centers on marketing without an approved NDA or ANDA. Consumers and healthcare providers should stop using the product immediately and contact ibspot for guidance.
STAQ Pharma’s Hydromorphone HCl PF 10mg/50mL IV injection recall affects nationwide distribution in the United States. The recall cites labeling errors involving incorrect or missing lot and expiration dates. Healthcare providers and patients must stop using the product and follow guidance from STAQ Pharma or their clinician.